NYMTI(NYMTI)
NYMTI
No analyst ratings available
No analyst price targets available for NYMTI
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $199M | $200M |
| Low | $199M | $200M |
| High | $199M | $200M |
| EBITDA Avg | $85M | $85M |
| Low | $85M | $85M |
| High | $85M | $85M |
| EBIT Avg | $13M | $13M |
| Low | $13M | $13M |
| High | $13M | $13M |
| Net Income Avg | $80M | $91M |
| Low | $80M | $91M |
| High | $80M | $91M |
| EPS Avg | $0.87 | $1.00 |
| Low | $0.87 | $1.00 |
| High | $0.87 | $1.00 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 |
| Metric | Q2 2026 | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|---|
| Revenue Avg | $50M | $50M | $49M | $50M | $50M | $50M | $50M |
| Low | $50M | $50M | $49M | $50M | $50M | $50M | $50M |
| High | $50M | $50M | $49M | $50M | $50M | $50M | $50M |
| EBITDA Avg | $21M | $21M | $21M | $21M | $21M | $21M | $21M |
| Low | $21M | $21M | $21M | $21M | $21M | $21M | $21M |
| High | $21M | $21M | $21M | $21M | $21M | $21M | $21M |
| EBIT Avg | $3M | $3M | $3M | $3M | $3M | $3M | $3M |
| Low | $3M | $3M | $3M | $3M | $3M | $3M | $3M |
| High | $3M | $3M | $3M | $3M | $3M | $3M | $3M |
| Net Income Avg | $21M | $21M | $21M | $23M | $23M | $23M | $23M |
| Low | $21M | $21M | $21M | $23M | $23M | $23M | $23M |
| High | $21M | $21M | $21M | $23M | $23M | $23M | $23M |
| EPS Avg | $0.23 | $0.23 | $0.22 | $0.25 | $0.25 | $0.25 | $0.25 |
| Low | $0.23 | $0.23 | $0.22 | $0.25 | $0.25 | $0.25 | $0.25 |
| High | $0.23 | $0.23 | $0.22 | $0.25 | $0.25 | $0.25 | $0.25 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |